🚨FDA 🚨Accelerates Approval of Afamitresgene Autoleucel for Advanced Synovial Sarcoma oncologytube.com/fda-accelerate… #FDAApproval #AfamitresgeneAutoleucel #TECELRA #SynovialSarcoma #CancerTreatment #Immunotherapy #MAGEA4 #Oncology #CancerResearch #AdvancedSarcoma #Biotech #MedicalNews

📺 VIDEO: 90% Patients Unaware Of Simple Genetic Test for Cancer - Kevin Hughes, MD MUSC Health oncologytube.com/90-patients-un… ASBrS Natera #GeneticTesting #CancerPrevention #Oncology #KevinHughesMD #MUSCHealth #PointOfCareTesting #CancerAwareness #NRDNA #BRCA #LynchSyndrome

📺 VIDEO: Breast Cancer Genetic Testing - When Should Doctors Use ctDNA? Nathalie McDowell Johnson, MD  oncologytube.com/breast-cancer-… Legacy Health ASBrS #ASBRS24 Natera #BreastCancer #Oncology #ctDNA #DrNathalieJohnson #CancerResearch #TripleNegativeBreastCancer

FDA Approved #Lazcluze #Rybrevant Combo in Advanced #NSCLC: Data Revealed to Oncologists The ASCO Post JanssenUS Johnson & Johnson #MARIPOSA #EGFR

Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024 AVEO Oncology #ESMO2024 Dana-Farber

Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024 by Toni Choueiri oncologytube.com/nivolumab-comb… AVEO Oncology #ESMO24 Dana-Farber

WATCH: FDA Approves Durvalumab / IMFINZI® for Resectable #NSCLC Non-Small Cell Lung Cancer AstraZeneca AEGEAN trial FDA Oncology

x.com/i/article/1834…

VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-L1 Cancer Immunotherapy in #NSCLC youtu.be/hdsH8rLgwZQ FDA Oncology Genentech #Immunotherapy

VIDEO: #FDA Approves #Atezolizumab / #Tecentriq Hybreza™️ For Subcutaneous PD-(L)1 Cancer #Immunotherapy in #NSCLC #SCLC Genentech

#ESMO24 2024: TIGIT Combo Delivers Significant Improvement in Lung Cancer Treatment #GSK iTeos Therapeutics #lungcancer #PD1Inhibitors #TIGITTherapy #NSCLC #Immunotherapy #Belrestotug #Dostarlimab #GALAXIESLung301

VIDEO: iTeos and GSK’s TIGIT Combination Therapy Shows Significant Promise at ESMO 2024 oncologytube.com/video-iteos-an… #ESMO24 #iTeos #GSK #TIGITtherapy #NSCLC #lungcancer #ESMO2024 #belrestotug #dostarlimab #Jemperli #tumorshrinkage #immunotherapy #PDL1 #checkpointinhibitors

VIDEO & SLIDES: FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer #ESMO24 oncologytube.com/slides-fda-app… FDA Oncology Novartis Breast Cancer Now @CancerResrchUK American Cancer Society OncoAlert Novartis News #Kisqali #Ribociclib #BreastCancer #FDAApproval #CancerResearch

Register for the 6th Annual LEAD Conference for women in hematology and oncology on Sept 27-28 at the Loews Coronado Bay Resort in San Diego! MOASC members can receive 20% off their registration when they use the code 20LEAD24. More info at LEADoncology.com

VIDEO: FDA approves KEYTRUDA® / Pembrolizumab with Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma oncologytube.com/fda-approves-k… Adam Merkley FDA Oncology #Immunotherapy #LungCancer #Oncology

NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Natera AACR @ESMO_org #ctDNA #CancerResearch #SurvivalRates #TreatmentResponse #ESMO2024 #Natera #GALAXYStudy #Oncology #CancerTreatment #MinimalResidualDisease #MRD #ColorectalCancer